News
March
February
Feb.22, 2024
Release
FETROJA® (cefiderocol) Approved by TFDA in Taiwan
Feb.02, 2024
Notice
Transcript of the FY2023 3Q Financial Results Conference
January
Jan.31, 2024
Notice
Financial Results and supplement for FY2023 3Q
Jan.31, 2024
Notice
Presentation Materials for FY2023 3Q financial results
Jan.25, 2024
Release
Notice of Investment Agreement with Niremia Collective
Jan.05, 2024
Notice
Regarding the "the ‘2024 (Reiwa 6) Noto Peninsula Earthquake" Disaster Situation